HIGH

Medtronic MiniMed Paradigm Real-Time Insulin Pump Recalled for 29,074 Units Worldwide (2026)

Medtronic MiniMed recalled 29,074 Paradigm Real-Time insulin pumps worldwide. The devices may deliver insulin improperly when the pump is elevated or lowered relative to the infusion site due to gravitational effects. Patients should stop using the pumps immediately and follow recall instructions from the manufacturer and their healthcare provider.

Quick Facts at a Glance

Recall Date
February 13, 2026
Hazard Level
HIGH
Brand
Medtronic MiniMed
Category
Health & Personal Care
Sold At
Multiple Retailers
Geographic Scope
1 states
At-Risk Groups
GENERAL

Hazard Information

All Medtronic MiniMed infusion pumps (Paradigm series, 600 series, and BLE 700 series) were found to be affected by unintended over- and under-delivery of insulin when the pump is elevated or lowered relative to the infusion site, respectively, because of changes in gravitational force impacting hydrostatic and hydrodynamic pressures. Insulin over-delivery, which can occur when the pump is elevated relative to the infusion site, can result in severe hypoglycemia, altered mental status, seizure, coma, or death. An under-delivery of insulin, which can occur at lowered pump height conditions relative to the infusion site, can result in severe hyperglycemia, dehydration, diabetic ketoacidosis, or death.

What You Should Do

Patients and healthcare providers should stop using this device immediately. Follow the recall instructions provided by the manufacturer. Contact Medtronic MiniMed, Inc. or your healthcare provider for instructions. Notification method: Letter

Get instant alerts for Health & Personal Care recalls

Be the first to know. Free instant alerts to your inbox.

No spamUnsubscribe anytime

About This Product

Medtronic MiniMed Paradigm Real-Time insulin pumps are wearable devices used for continuous insulin delivery in diabetes management. They are part of a family of infusion pumps designed to automate insulin dosing.

Why This Is Dangerous

The device can over-deliver insulin when elevated and under-deliver when lowered, due to changes in hydrostatic and hydrodynamic pressures. This can lead to severe hypoglycemia or diabetic ketoacidosis and potentially death.

Industry Context

This recall is not described as part of a broader industry pattern in the provided data.

Real-World Impact

The risk is life-threatening for some users. The recall affects patients who rely on these pumps for daily management and may require urgent medical oversight during replacement.

Practical Guidance

How to identify if yours is affected

  1. Verify your pump model against MMT-522 or MMT-722.
  2. Locate the device's UDI/serial numbers and compare with Medtronic recall list.
  3. Check recall notification letter from Medtronic or FDA notice on enforcement page.

Where to find product info

Recall notices are available from Medtronic and FDA enforcement reports. Useful identifiers include model number and device documentation.

What timeline to expect

4-8 weeks for refunds or replacements after initiating the recall process.

If the manufacturer is unresponsive

  • Document all communications with the manufacturer and clinician.
  • File a complaint with the FDA if the company is non-responsive.
  • Consider seeking guidance from a medical professional for interim diabetes management.

How to prevent similar issues

  • Avoid purchasing older Paradigm/600-series pumps; verify recall status before use.
  • Verify device with manufacturer before starting any replacement plan.
  • Ask about safer, modern insulin pump systems with updated safety features.

Documentation advice

Keep recall letter, model numbers, serials, photos of device, and all correspondence with manufacturer and clinicians.

Product Details

Models: MMT-522, MMT-722. Affected series: Paradigm Real-Time, MiniMed 600 series, BLE 700 series. Sold worldwide with US nationwide distribution in multiple states. Recall quantity: 29,074 units. Recall date: 2026-02-13. Manufacturer: Medtronic MiniMed, Inc. Price information: Unknown. Sold since: Unknown. Country of origin: Unknown.

Reported Incidents

No injuries or incidents have been reported.

Key Facts

  • 29,074 units recalled
  • Models MMT-522 and MMT-722
  • Worldwide distribution including US states listed
  • Recall date 2026-02-13
  • Hazard: unintended insulin delivery due to pump height
  • No injuries or incidents reported

Safety Guide

Not sure what to do next? Our guide walks you through the process step by step.

Read: What to Do When You Find a Recalled Product

Get Alerts for Health & Personal Care Recalls

Get instant alerts for recalls that affect you. Free forever.

Safety Assessment

Risk LevelHIGH
Severity Score
9/ 10
Affected Groups
GENERAL
Injury Types
OTHER

Product Details

Model Numbers
MMT-522
MMT-722
Paradigm Real-Time Insulin Pump
Affected States
ALL
Report Date
April 8, 2026
Recall Status
ACTIVE

Related Recalls

Health & Personal Care
HIGH

Medtronic MiniMed 780G Insulin Pump Recalled for 453,144 Units Worldwide (2026)

Medtronic recalled 453,144 MiniMed 780G insulin pumps worldwide after reports of unintended insulin delivery when the pump height changes relative to the infusion site. The defect stems from gravity-driven pressure changes affecting hydrostatic delivery. Patients and caregivers should stop using the devices immediately and follow the recall notice, contacting Medtronic MiniMed or their clinician’s

Medtronic MiniMed
All Medtronic
Read more
Health & Personal Care
HIGH

Medtronic MiniMed 740G Insulin Pump Recalled for 24,946 Units Worldwide (2026)

Medtronic MiniMed recalled 24,946 MiniMed 740G insulin pumps worldwide after identifying unintended insulin delivery when the pump height changes relative to the infusion site. The defect can cause over-delivery or under-delivery of insulin due to gravity-driven pressure changes. Patients should stop using the device and contact Medtronic MiniMed for instructions on recall steps, refunds or a swap

Medtronic MiniMed
All Medtronic
Read more
Health & Personal Care
HIGH

Medtronic MiniMed Paradigm Revel Insulin Pumps Recalled: 26,647 Units Worldwide (2026)

Medtronic MiniMed recalled 26,647 Paradigm REAL-Time Revel insulin pumps distributed worldwide, including in the United States. A design flaw can cause insulin to be over- or under-delivered when the pump height changes relative to the infusion site. Patients and health providers should stop using the device immediately and follow the manufacturer’s recall instructions. The recall covers Paradigm,

Medtronic MiniMed
All Medtronic
Read more
Health & Personal Care
HIGH

Medtronic MiniMed 720G Insulin Pump Recall 2026 Affects 37,458 Units Worldwide

Medtronic MiniMed recalled 37,458 insulin pumps sold worldwide through healthcare providers, including the MiniMed 720G, after finding that a pump raised above or lowered relative to the infusion site can deliver insulin too much or too little. The defect stems from changes in gravitational force affecting hydrostatic and hydrodynamic pressures at the infusion site. Patients should stop using the

Medtronic MiniMed
All Medtronic
Read more
Health & Personal Care
HIGH

Medtronic MiniMed Paradigm Veo Insulin Pump Recalled for 55,724 Units (2026)

Medtronic MiniMed recalls 55,724 Paradigm REAL-Time Veo insulin pumps distributed worldwide. The pumps can deliver too much insulin when raised or too little when lowered relative to the infusion site due to gravity-driven pressure changes. Patients should stop using the device and contact Medtronic MiniMed or their healthcare provider for instructions and refunds.

Medtronic MiniMed
All Medtronic
Read more
Health & Personal Care
HIGH

Medtronic MiniMed 700G Insulin Pump Recalled for Insulin Delivery Errors (13,811 Units, 2026)

Medtronic MiniMed recalled 13,811 MiniMed 700G insulin pumps sold worldwide through multiple retailers. The pumps can deliver too much or too little insulin when the pump height relative to the infusion site changes due to gravity. Consumers should stop using the device and follow recall instructions in the letter notice sent to affected users.

Medtronic MiniMed
All Medtronic
Read more
Health & Personal Care
HIGH

Medtronic MiniMed Paradigm Insulin Pumps Recalled 73,656 Units Worldwide in 2026

Medtronic MiniMed recalled 73,656 Paradigm insulin pumps sold worldwide, including broad U.S. distribution, after a risk of unintended insulin delivery. The issue affects Paradigm, 600-series and BLE 700-series pumps. It can cause life-threatening highs or lows in insulin delivery. Stop using the device and follow recall instructions immediately.

Medtronic MiniMed
All Medtronic
Read more